INDIANAPOLIS — Eli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker. Lilly also hiked its forecast for the year well beyond Wall Street expectations as newer drugs like Zepbound built momentum. Leerink Partners analyst David Risinger noted that insurance coverage of Zepbound …
Injectable weight-loss drugs can prevent serious health problems, which makes them extremely valuable. The financial impact on Medicare is tempered by a 2003 federal law that prevents the government health insurance program from covering weight-loss medications.The drugs can be added to formularies if prescribed for another “medically accepted indication,” such as to treat type 2 diabetes or reduce heart risk, …
CNN — About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are currently using a prescription, according to new survey data from KFF. But about 2 in 5 adults …
CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …
Zepbound, a new version of the popular diabetes treatment Mounjaro, received government approval Wednesday to be sold as a weight-loss drug. Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. “This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. …
When she prescribes the popular weight-loss drug Wegovy, Dr. Angela Fitch sends patients on a quest she likens to “The Hunger Games.” They will have to call drugstores over several days to find one with the properly sized first dose. Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and …